These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18053582)

  • 1. Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration.
    Carpenter EL; Vance BA; Klein RS; Voloschin A; Dalmau J; Vonderheide RH
    J Neuroimmunol; 2008 Jan; 193(1-2):173-82. PubMed ID: 18053582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
    Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
    J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.
    Albert ML; Austin LM; Darnell RB
    Ann Neurol; 2000 Jan; 47(1):9-17. PubMed ID: 10632096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
    Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
    Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
    Panja D; Vedeler CA; Schubert M
    Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A T-cell receptor associated with naturally occurring human tumor immunity.
    Santomasso BD; Roberts WK; Thomas A; Williams T; Blachère NE; Dudley ME; Houghton AN; Posner JB; Darnell RB
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19073-8. PubMed ID: 18045792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.
    Herdlevaer I; Kråkenes T; Schubert M; Vedeler CA
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2231-2242. PubMed ID: 33009713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization.
    Sakai K; Shirakawa T; Kitagawa Y; Li Y; Hirose G
    J Autoimmun; 2001 Dec; 17(4):297-302. PubMed ID: 11771954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.
    Eichler TW; Totland C; Haugen M; Qvale TH; Mazengia K; Storstein A; Haukanes BI; Vedeler CA
    PLoS One; 2013; 8(6):e66002. PubMed ID: 23823982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
    Yshii L; Bost C; Liblau R
    Front Immunol; 2020; 11():991. PubMed ID: 32655545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.
    Schubert M; Panja D; Haugen M; Bramham CR; Vedeler CA
    Acta Neuropathol; 2014 Dec; 128(6):835-52. PubMed ID: 25341622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDR2 antigen and Yo antibodies.
    Totland C; Aarskog NK; Eichler TW; Haugen M; Nøstbakken JK; Monstad SE; Salvesen HB; Mørk S; Haukanes BI; Vedeler CA
    Cancer Immunol Immunother; 2011 Feb; 60(2):283-9. PubMed ID: 21080165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
    Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
    Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
    Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
    Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
    Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
    Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration.
    Aye MM; Kasai T; Tashiro Y; Xing HQ; Shirahama H; Mitsuda M; Suetsugu T; Tanaka K; Osame M; Izumo S
    J Neuroimmunol; 2009 Mar; 208(1-2):136-40. PubMed ID: 19217169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
    Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
    J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
    Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
    Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors.
    Darnell JC; Albert ML; Darnell RB
    Cancer Res; 2000 Apr; 60(8):2136-9. PubMed ID: 10786675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.
    Ducray F; Demarquay G; Graus F; Decullier E; Antoine JC; Giometto B; Psimaras D; Delattre JY; Carpentier AF; Honnorat J
    Eur J Neurol; 2014 May; 21(5):731-5. PubMed ID: 24471811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.